Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The menopausal syndrome.

P F Brenner1

  • 1Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.

Obstetrics and Gynecology
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Estrogen replacement therapy effectively manages menopausal symptoms like hot flashes and prevents genitourinary atrophy. This therapy is safe for most women, offering bone and cardiovascular protection during postmenopause.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive health of the young and the elderly in the USA.

Advances in contraception : the official journal of the Society for the Advancement of Contraception·1996
Same author

Differential diagnosis of abnormal uterine bleeding.

American journal of obstetrics and gynecology·1996
Same author

Management of abnormal uterine bleeding.

American journal of obstetrics and gynecology·1996
Same author

Biologic effects of equilin sulfate in postmenopausal women.

Fertility and sterility·1988
Same author

Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose.

Contraception·1987
Same author

Pregnancy termination with a high and medium dosage regimen of RU 486.

Contraception·1986
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
Same journal

PUBLICATIONS: July 2026.

Obstetrics and gynecology·2026
Same journal

Vaginal Natural Orifice Transluminal Endoscopic Surgery in Minimally Invasive Gynecologic Surgery: Correction.

Obstetrics and gynecology·2026
Same journal

A Contemporary View of Menopausal Hormone Therapy: Correction.

Obstetrics and gynecology·2026
Same journal

In Reply.

Obstetrics and gynecology·2026
See all related articles

Area of Science:

  • Women's Health
  • Menopause Management
  • Hormone Therapy

Background:

  • Postmenopausal women face significant health challenges, including genitourinary atrophy and vasomotor symptoms.
  • Vasomotor symptoms like hot flashes affect a large percentage of postmenopausal women, often persisting for years.
  • Current use of estrogen replacement therapy (ERT) among eligible women remains low.

Purpose of the Study:

  • To evaluate the efficacy and safety of estrogen replacement therapy (ERT) for managing postmenopausal symptoms.
  • To highlight the benefits of ERT in preventing genitourinary atrophy and protecting bone and cardiovascular health.

Main Methods:

  • Review of existing data on estrogen replacement therapy (ERT) in postmenopausal women.
  • Analysis of symptom prevalence and duration in the absence of ERT.

Related Experiment Videos

  • Assessment of ERT's impact on genitourinary health, bone density, and cardiovascular markers.

    • Main Results:

    • Estrogen therapy can prevent or reverse genitourinary atrophy.
    • Approximately 75% of postmenopausal women experience severe vasomotor symptoms, with many experiencing prolonged hot flashes.
    • ERT is identified as the primary treatment for vasomotor symptoms and is considered safe for most postmenopausal women.

    Conclusions:

    • Estrogen replacement therapy is a safe and effective treatment for managing menopausal vasomotor symptoms.
    • ERT offers significant benefits, including protection of bone health and the cardiovascular system.
    • Increased consideration of ERT is warranted for eligible postmenopausal women experiencing relevant symptoms.